Literature DB >> 25416779

Charge neutralization of the central lysine cluster in prion protein (PrP) promotes PrP(Sc)-like folding of recombinant PrP amyloids.

Bradley R Groveman1, Allison Kraus1, Lynne D Raymond1, Michael A Dolan2, Kelsie J Anson1, David W Dorward3, Byron Caughey4.   

Abstract

The structure of the infectious form of prion protein, PrP(Sc), remains unclear. Most pure recombinant prion protein (PrP) amyloids generated in vitro are not infectious and lack the extent of the protease-resistant core and solvent exclusion of infectious PrP(Sc), especially within residues ∼90-160. Polyanionic cofactors can enhance infectivity and PrP(Sc)-like characteristics of such fibrils, but the mechanism of this enhancement is unknown. In considering structural models of PrP(Sc) multimers, we identified an obstacle to tight packing that might be overcome with polyanionic cofactors, namely, electrostatic repulsion between four closely spaced cationic lysines within a central lysine cluster of residues 101-110. For example, in our parallel in-register intermolecular β-sheet model of PrP(Sc), not only would these lysines be clustered within the 101-110 region of the primary sequence, but they would have intermolecular spacings of only ∼4.8 Å between stacked β-strands. We have now performed molecular dynamics simulations predicting that neutralization of the charges on these lysine residues would allow more stable parallel in-register packing in this region. We also show empirically that substitution of these clustered lysine residues with alanines or asparagines results in recombinant PrP amyloid fibrils with extended proteinase-K resistant β-sheet cores and infrared spectra that are more reminiscent of bona fide PrP(Sc). These findings indicate that charge neutralization at the central lysine cluster is critical for the folding and tight packing of N-proximal residues within PrP amyloid fibrils. This charge neutralization may be a key aspect of the mechanism by which anionic cofactors promote PrP(Sc) formation.
© 2015 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  Amyloid; Mutagenesis; Prion; Prion Disease; Protein Folding; Protein Structure

Mesh:

Substances:

Year:  2014        PMID: 25416779      PMCID: PMC4294479          DOI: 10.1074/jbc.M114.619627

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  56 in total

1.  Formation of native prions from minimal components in vitro.

Authors:  Nathan R Deleault; Brent T Harris; Judy R Rees; Surachai Supattapone
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-29       Impact factor: 11.205

2.  Ultrasensitive detection of scrapie prion protein using seeded conversion of recombinant prion protein.

Authors:  Ryuichiro Atarashi; Roger A Moore; Valerie L Sim; Andrew G Hughson; David W Dorward; Henry A Onwubiko; Suzette A Priola; Byron Caughey
Journal:  Nat Methods       Date:  2007-07-22       Impact factor: 28.547

3.  Cofactor molecules induce structural transformation during infectious prion formation.

Authors:  Michael B Miller; Daphne W Wang; Fei Wang; Geoffrey P Noble; Jiyan Ma; Virgil L Woods; Sheng Li; Surachai Supattapone
Journal:  Structure       Date:  2013-10-10       Impact factor: 5.006

4.  Parallel in-register intermolecular β-sheet architectures for prion-seeded prion protein (PrP) amyloids.

Authors:  Bradley R Groveman; Michael A Dolan; Lara M Taubner; Allison Kraus; Reed B Wickner; Byron Caughey
Journal:  J Biol Chem       Date:  2014-07-15       Impact factor: 5.157

5.  Generating a prion with bacterially expressed recombinant prion protein.

Authors:  Fei Wang; Xinhe Wang; Chong-Gang Yuan; Jiyan Ma
Journal:  Science       Date:  2010-01-28       Impact factor: 47.728

6.  Mammalian prions generated from bacterially expressed prion protein in the absence of any mammalian cofactors.

Authors:  Jae-Il Kim; Ignazio Cali; Krystyna Surewicz; Qingzhong Kong; Gregory J Raymond; Ryuichiro Atarashi; Brent Race; Liuting Qing; Pierluigi Gambetti; Byron Caughey; Witold K Surewicz
Journal:  J Biol Chem       Date:  2010-03-19       Impact factor: 5.157

7.  Rapid end-point quantitation of prion seeding activity with sensitivity comparable to bioassays.

Authors:  Jason M Wilham; Christina D Orrú; Richard A Bessen; Ryuichiro Atarashi; Kazunori Sano; Brent Race; Kimberly D Meade-White; Lara M Taubner; Andrew Timmes; Byron Caughey
Journal:  PLoS Pathog       Date:  2010-12-02       Impact factor: 6.823

8.  Molecular architecture of human prion protein amyloid: a parallel, in-register beta-structure.

Authors:  Nathan J Cobb; Frank D Sönnichsen; Hassane McHaourab; Witold K Surewicz
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-19       Impact factor: 11.205

9.  Heparin binding confers prion stability and impairs its aggregation.

Authors:  Tuane C R G Vieira; Yraima Cordeiro; Byron Caughey; Jerson L Silva
Journal:  FASEB J       Date:  2014-03-19       Impact factor: 5.191

10.  Structural organization of brain-derived mammalian prions examined by hydrogen-deuterium exchange.

Authors:  Vytautas Smirnovas; Gerald S Baron; Danielle K Offerdahl; Gregory J Raymond; Byron Caughey; Witold K Surewicz
Journal:  Nat Struct Mol Biol       Date:  2011-03-27       Impact factor: 15.369

View more
  23 in total

1.  Prion Protein Prolines 102 and 105 and the Surrounding Lysine Cluster Impede Amyloid Formation.

Authors:  Allison Kraus; Kelsie J Anson; Lynne D Raymond; Craig Martens; Bradley R Groveman; David W Dorward; Byron Caughey
Journal:  J Biol Chem       Date:  2015-07-14       Impact factor: 5.157

2.  The real-time quaking-induced conversion assay for detection of human prion disease and study of other protein misfolding diseases.

Authors:  Matthias Schmitz; Maria Cramm; Franc Llorens; Dominik Müller-Cramm; Steven Collins; Ryuichiro Atarashi; Katsuya Satoh; Christina D Orrù; Bradley R Groveman; Saima Zafar; Walter J Schulz-Schaeffer; Byron Caughey; Inga Zerr
Journal:  Nat Protoc       Date:  2016-10-13       Impact factor: 13.491

3.  A Promising Antiprion Trimethoxychalcone Binds to the Globular Domain of the Cellular Prion Protein and Changes Its Cellular Location.

Authors:  N C Ferreira; L M Ascari; A G Hughson; G R Cavalheiro; C F Góes; P N Fernandes; J R Hollister; R A da Conceição; D S Silva; A M T Souza; M L C Barbosa; F A Lara; R A P Martins; B Caughey; Y Cordeiro
Journal:  Antimicrob Agents Chemother       Date:  2018-01-25       Impact factor: 5.191

4.  Million-fold sensitivity enhancement in proteopathic seed amplification assays for biospecimens by Hofmeister ion comparisons.

Authors:  Michael A Metrick; Natalia do Carmo Ferreira; Eri Saijo; Andrew G Hughson; Allison Kraus; Christina Orrú; Michael W Miller; Gianluigi Zanusso; Bernardino Ghetti; Michele Vendruscolo; Byron Caughey
Journal:  Proc Natl Acad Sci U S A       Date:  2019-10-22       Impact factor: 11.205

5.  PrP P102L and Nearby Lysine Mutations Promote Spontaneous In Vitro Formation of Transmissible Prions.

Authors:  Allison Kraus; Gregory J Raymond; Brent Race; Katrina J Campbell; Andrew G Hughson; Kelsie J Anson; Lynne D Raymond; Byron Caughey
Journal:  J Virol       Date:  2017-10-13       Impact factor: 5.103

6.  Proline and lysine residues provide modulatory switches in amyloid formation: Insights from prion protein.

Authors:  Allison Kraus
Journal:  Prion       Date:  2016       Impact factor: 3.931

7.  Detection of Atypical H-Type Bovine Spongiform Encephalopathy and Discrimination of Bovine Prion Strains by Real-Time Quaking-Induced Conversion.

Authors:  Kentaro Masujin; Christina D Orrú; Kohtaro Miyazawa; Bradley R Groveman; Lynne D Raymond; Andrew G Hughson; Byron Caughey
Journal:  J Clin Microbiol       Date:  2016-01-06       Impact factor: 5.948

8.  PrPSc-Specific Antibody Reveals C-Terminal Conformational Differences between Prion Strains.

Authors:  Eri Saijo; Andrew G Hughson; Gregory J Raymond; Akio Suzuki; Motohiro Horiuchi; Byron Caughey
Journal:  J Virol       Date:  2016-04-29       Impact factor: 5.103

9.  Molecular tweezers for lysine and arginine - powerful inhibitors of pathologic protein aggregation.

Authors:  Thomas Schrader; Gal Bitan; Frank-Gerrit Klärner
Journal:  Chem Commun (Camb)       Date:  2016-08-22       Impact factor: 6.222

10.  Mammalian amyloidogenic proteins promote prion nucleation in yeast.

Authors:  Pavithra Chandramowlishwaran; Meng Sun; Kristin L Casey; Andrey V Romanyuk; Anastasiya V Grizel; Julia V Sopova; Aleksandr A Rubel; Carmen Nussbaum-Krammer; Ina M Vorberg; Yury O Chernoff
Journal:  J Biol Chem       Date:  2018-01-12       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.